✦ LIBER ✦

Phase II study of paclitaxel as first line treatment for patients with extensive stage small cell lung cancer (SCLC)

✍ Scribed by Langley, R.E.; Woll, P.J.; Davidson, N.; Libretti, V.; Smyth, J.F.; Schipper, R; Carmichael, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-560 Phase I-II study of amrubicin and

✍ Matsui, Kaoru; Ohe, Yuichiro; Negoro, Shunichi; Nakagawa, Kazuhiko; Sugiura, Tak 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 374 KB

A phase II trial of paclitaxel in previo

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 61 KB

P-766 Phase II study of topotecan (T) an

✍ Hainsworth, J.; Palmer, M.; Granick, J.; Boston, B.; Bonomi, P.; Althouse, D.; D 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Phase II study of maintenance sunitinib

✍ Spigel, David R.; Greco, F. Anthony; Rubin, Mark S.; Shipley, Dianna; Thompson, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 407 KB

A phase II study of paclitaxel (P) and c

✍ Agelaki, S.; Agelidou, M.; Blazogiannakis, G.; Tsiafaki, X.; Palamidas, Th.; Kou 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 325 KB

Randomized, phase II study of topotecan/

✍ H. Lena; J. Breton; W. Yu; K. Steppert; K. Lightcap; G. Ross; M. Lymboura 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB